HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.

PubWeight™: 6.54‹?› | Rank: Top 1%

🔗 View Article (PMID 1760846)

Published in Cell on December 20, 1991

Authors

A Engelman1, K Mizuuchi, R Craigie

Author Affiliations

1: Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

Associated clinical trials:

GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance | NCT01381328

Articles citing this

(truncated to the top 100)

Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77

Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07

Retroviral intasome assembly and inhibition of DNA strand transfer. Nature (2010) 4.99

Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J (1993) 4.39

Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol (1995) 4.27

Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99

LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev (2007) 3.96

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol (1992) 3.85

Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J (2006) 3.68

Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol (1995) 3.56

Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc Natl Acad Sci U S A (1992) 3.55

Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res (1993) 3.42

Complementation between HIV integrase proteins mutated in different domains. EMBO J (1993) 3.32

Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations. J Virol (1993) 3.28

Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc Natl Acad Sci U S A (2000) 3.26

Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J (2001) 3.23

Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol (1996) 2.82

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro. Antimicrob Agents Chemother (2008) 2.61

The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol (1994) 2.56

DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes. EMBO J (1994) 2.48

Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137). J Virol (2007) 2.33

Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination. Genes Dev (1999) 2.28

Genetic analysis of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 2.26

Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J Virol (1995) 2.22

Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc Natl Acad Sci U S A (1994) 2.20

Loss of raltegravir susceptibility by human immunodeficiency virus type 1 is conferred via multiple nonoverlapping genetic pathways. J Virol (2009) 2.19

Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J Virol (1992) 2.02

The lentiviral integrase binding protein LEDGF/p75 and HIV-1 replication. PLoS Pathog (2008) 2.00

Identification of residues in the Mu transposase essential for catalysis. Proc Natl Acad Sci U S A (1994) 1.94

A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J (1997) 1.94

Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci U S A (1993) 1.91

Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature (2015) 1.89

Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase. J Virol (1995) 1.87

Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A (2007) 1.85

HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature (2013) 1.84

Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J Virol (1994) 1.84

Resistance mutations in human immunodeficiency virus type 1 integrase selected with elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors. J Virol (2008) 1.83

An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J Virol (1994) 1.81

Drosophila P-element transposase is a novel site-specific endonuclease. Genes Dev (1997) 1.80

Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis. Nucleic Acids Res (1993) 1.79

Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes. EMBO J (2001) 1.77

Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase. J Virol (1992) 1.74

The Tn7 transposase is a heteromeric complex in which DNA breakage and joining activities are distributed between different gene products. EMBO J (1996) 1.74

HIV DNA integration. Cold Spring Harb Perspect Med (2012) 1.73

Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol (1996) 1.72

Retroviral DNA integration. Microbiol Mol Biol Rev (1999) 1.64

Identification and characterization of a pre-cleavage synaptic complex that is an early intermediate in Tn10 transposition. EMBO J (1995) 1.55

HIV-1 IN inhibitors: 2010 update and perspectives. Curr Top Med Chem (2009) 1.53

Relationship between retroviral DNA integration and gene expression. J Virol (2000) 1.53

Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. J Virol (1999) 1.52

Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proc Natl Acad Sci U S A (1992) 1.52

Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci (2008) 1.50

Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol (1996) 1.50

3'-processing and strand transfer catalysed by retroviral integrase in crystallo. EMBO J (2012) 1.49

Integrase and integration: biochemical activities of HIV-1 integrase. Retrovirology (2008) 1.48

Complementation of integrase function in HIV-1 virions. EMBO J (1997) 1.46

Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates. J Virol (1994) 1.45

Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation. J Virol (1998) 1.44

Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. Nucleic Acids Res (1994) 1.40

Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol (2013) 1.34

Regulatory mechanisms by which barrier-to-autointegration factor blocks autointegration and stimulates intermolecular integration of Moloney murine leukemia virus preintegration complexes. J Virol (2002) 1.34

Endonucleolytic cleavages and DNA-joining activities of the integration protein of human foamy virus. J Virol (1993) 1.33

Retroviral integration: in vitro host site selection by avian integrase. J Virol (1994) 1.33

Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. EMBO J (2009) 1.32

Effect of raltegravir resistance mutations in HIV-1 integrase on viral fitness. J Acquir Immune Defic Syndr (2010) 1.30

Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase. Nucleic Acids Res (1994) 1.29

The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. J Virol (2000) 1.27

Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. Antimicrob Agents Chemother (2009) 1.27

Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res (1993) 1.27

Comparison of DNA binding and integration half-site selection by avian myeloblastosis virus integrase. J Virol (1993) 1.26

Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding. J Biol Chem (2007) 1.26

Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J Virol (1993) 1.25

Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci U S A (1992) 1.20

Retroviral integrase proteins and HIV-1 DNA integration. J Biol Chem (2012) 1.20

Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases. J Virol (1995) 1.19

Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci U S A (1995) 1.18

Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness. Antimicrob Agents Chemother (2013) 1.17

Human endogenous retrovirus K10 encodes a functional integrase. J Virol (1996) 1.16

DNA substrate requirements for different activities of the human immunodeficiency virus type 1 integrase protein. J Virol (1994) 1.15

Tn 10 transposition in vivo: temporal separation of cleavages at the two transposon ends and roles of terminal basepairs subsequent to interaction of ends. EMBO J (1994) 1.15

Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy. J Mol Biol (2010) 1.14

Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids. J Virol (1999) 1.14

Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. Proc Natl Acad Sci U S A (1994) 1.13

Amino acid sequence homology between Piv, an essential protein in site-specific DNA inversion in Moraxella lacunata, and transposases of an unusual family of insertion elements. J Bacteriol (1994) 1.12

Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob Agents Chemother (2001) 1.09

Substrate specificity of Ty1 integrase. J Virol (1995) 1.09

Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins. J Virol (1998) 1.09

Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase. J Virol (1994) 1.08

A novel DNA binding and nuclease activity in domain III of Mu transposase: evidence for a catalytic region involved in donor cleavage. EMBO J (1995) 1.08

Cross-resistance profile determination of two second-generation HIV-1 integrase inhibitors using a panel of recombinant viruses derived from raltegravir-treated clinical isolates. Antimicrob Agents Chemother (2010) 1.08

von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step. Proc Natl Acad Sci U S A (2007) 1.08

Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases. J Virol (1996) 1.08

Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA. J Mol Biol (2006) 1.07

Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virions. J Virol (2003) 1.06

Deciphering the code for retroviral integration target site selection. PLoS Comput Biol (2010) 1.06

Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes. Retrovirology (2009) 1.05

DNA binding and phasing analyses of Tn5 transposase and a monomeric variant. Nucleic Acids Res (1997) 1.05

Ty1 in vitro integration: effects of mutations in cis and in trans. Mol Cell Biol (1994) 1.04

Characterization of recombinant murine leukemia virus integrase. J Virol (1995) 1.03

In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state. Nucleic Acids Res (2008) 1.03

Articles by these authors

Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A (1977) 18.37

DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci U S A (1976) 17.42

Retroviral DNA integration: structure of an integration intermediate. Cell (1988) 8.48

Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science (1994) 6.69

Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc Natl Acad Sci U S A (1991) 6.58

Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol (1992) 6.07

Retroviral DNA integration directed by HIV integration protein in vitro. Science (1990) 5.87

DNA gyrase: subunit structure and ATPase activity of the purified enzyme. Proc Natl Acad Sci U S A (1978) 5.60

Crystal structure of an IHF-DNA complex: a protein-induced DNA U-turn. Cell (1996) 5.38

Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals. Cell (1987) 4.70

Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J (1993) 4.39

The defect in murine severe combined immune deficiency: joining of signal sequences but not coding segments in V(D)J recombination. Cell (1988) 4.34

Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol (1995) 4.27

Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99

V(D)J recombination: a functional definition of the joining signals. Genes Dev (1989) 3.96

DNA gyrase action involves the introduction of transient double-strand breaks into DNA. Proc Natl Acad Sci U S A (1980) 3.87

Developmental stage specificity of the lymphoid V(D)J recombination activity. Genes Dev (1987) 3.65

Similarities between initiation of V(D)J recombination and retroviral integration. Science (1996) 3.64

T4 endonuclease VII cleaves holliday structures. Cell (1982) 3.47

Site-specific recognition of the bacteriophage Mu ends by the Mu A protein. Cell (1984) 3.33

Restriction assay for integrative recombination of bacteriophage lambda DNA in vitro: requirement for closed circular DNA substrate. Proc Natl Acad Sci U S A (1976) 3.32

Integration of mini-retroviral DNA: a cell-free reaction for biochemical analysis of retroviral integration. Proc Natl Acad Sci U S A (1989) 3.28

Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J (2001) 3.23

DNA gyrase and DNA supercoiling. Cold Spring Harb Symp Quant Biol (1979) 3.16

A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci U S A (1998) 3.10

Cruciform structures in palindromic DNA are favored by DNA supercoiling. J Mol Biol (1982) 3.03

Structure and function of the phage lambda att site: size, int-binding sites, and location of the crossover point. Cold Spring Harb Symp Quant Biol (1981) 2.99

Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins. J Biol Chem (1984) 2.98

Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci U S A (1998) 2.98

DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res (1987) 2.93

Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J (1998) 2.84

Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol (1997) 2.81

Site-specific interaction of DNA gyrase with DNA. Proc Natl Acad Sci U S A (1981) 2.75

Transposition of Mu DNA: joining of Mu to target DNA can be uncoupled from cleavage at the ends of Mu. Cell (1987) 2.73

Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry (1995) 2.69

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc Natl Acad Sci U S A (1999) 2.69

Mechanism of transposition of bacteriophage Mu: structure of a transposition intermediate. Cell (1985) 2.59

A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization. J Biol Chem (1996) 2.58

The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol (1994) 2.56

A defined system for the DNA strand-transfer reaction at the initiation of bacteriophage Mu transposition: protein and DNA substrate requirements. Proc Natl Acad Sci U S A (1985) 2.50

Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci U S A (1996) 2.46

Structure of the bacteriophage Mu transposase core: a common structural motif for DNA transposition and retroviral integration. Cell (1995) 2.44

Slow cruciform transitions in palindromic DNA. Proc Natl Acad Sci U S A (1983) 2.42

Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J (1997) 2.42

Novel strand exchanges in V(D)J recombination. Cell (1988) 2.31

Assembly of the active form of the transposase-Mu DNA complex: a critical control point in Mu transposition. Cell (1992) 2.30

Mechanism of bacteriophage mu transposition. Annu Rev Genet (1986) 2.26

Protection of retroviral DNA from autointegration: involvement of a cellular factor. Proc Natl Acad Sci U S A (1994) 2.20

Role of DNA topology in Mu transposition: mechanism of sensing the relative orientation of two DNA segments. Cell (1986) 2.18

The phage Mu transpososome core: DNA requirements for assembly and function. EMBO J (1995) 2.14

Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc Natl Acad Sci U S A (2000) 2.12

Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci U S A (1995) 2.09

In vitro transposition of bacteriophage Mu: a biochemical approach to a novel replication reaction. Cell (1983) 2.08

Mu transpositional recombination: donor DNA cleavage and strand transfer in trans by the Mu transposase. Cell (1996) 2.08

HIV integrase structure and function. Adv Virus Res (1999) 2.08

Involement of supertwisted DNA in integrative recombination of bacteriophage lambda. J Mol Biol (1978) 2.07

Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro. J Virol (1990) 2.06

Solution structure of the cellular factor BAF responsible for protecting retroviral DNA from autointegration. Nat Struct Biol (1998) 2.00

Integrative recombination of bacteriophage lambda: extent of the DNA sequence involved in attachment site function. Proc Natl Acad Sci U S A (1980) 1.97

Target immunity of Mu transposition reflects a differential distribution of Mu B protein. Cell (1988) 1.96

Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. Proc Natl Acad Sci U S A (1988) 1.95

A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J (1997) 1.94

Efficient Mu transposition requires interaction of transposase with a DNA sequence at the Mu operator: implications for regulation. Cell (1989) 1.93

DNA-promoted assembly of the active tetramer of the Mu transposase. Genes Dev (1992) 1.88

Integrative recombination of bacteriophage lambda: in vitro study of the intermolecular reaction. Cold Spring Harb Symp Quant Biol (1979) 1.86

Retroviral integrases and their cousins. Curr Opin Struct Biol (1996) 1.80

Regulation of DNA supercoiling in Escherichia coli. Cold Spring Harb Symp Quant Biol (1983) 1.77

MuB protein allosterically activates strand transfer by the transposase of phage Mu. Cell (1991) 1.75

Division of labor among monomers within the Mu transposase tetramer. Cell (1993) 1.73

A rapid in vitro assay for HIV DNA integration. Nucleic Acids Res (1991) 1.65

B protein of bacteriophage mu is an ATPase that preferentially stimulates intermolecular DNA strand transfer. Proc Natl Acad Sci U S A (1987) 1.64

Interaction of proteins located at a distance along DNA: mechanism of target immunity in the Mu DNA strand-transfer reaction. Cell (1989) 1.62

An efficient and cost-effective isotope labeling protocol for proteins expressed in Escherichia coli. J Biomol NMR (1998) 1.61

Regulation of the higher-order structure of chromatin by histones H1 and H5. J Cell Biol (1981) 1.58

DNA sequence and transcription of the region upstream of the E. coli gyrB gene. Nucleic Acids Res (1984) 1.57

Footprints on the viral DNA ends in moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc Natl Acad Sci U S A (1998) 1.53

LAP2 binds to BAF.DNA complexes: requirement for the LEM domain and modulation by variable regions. EMBO J (2001) 1.53

Integration of human immunodeficiency virus DNA: adduct interference analysis of required DNA sites. Proc Natl Acad Sci U S A (1992) 1.52

Stomatal vs. genome size in angiosperms: the somatic tail wagging the genomic dog? Ann Bot (2010) 1.47

Resolution of Holliday structures by endonuclease VII as observed in interactions with cruciform DNA. Cold Spring Harb Symp Quant Biol (1984) 1.45

Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J (2001) 1.42

Mechanism of transposition of bacteriophage Mu: polarity of the strand transfer reaction at the initiation of transposition. Cell (1984) 1.41

The extent of DNA sequence required for a functional bacterial attachment site of phage lambda. Nucleic Acids Res (1985) 1.39

Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity. J Virol (1995) 1.38

Strand exchange in lambda integrative recombination: genetics, biochemistry, and models. Cold Spring Harb Symp Quant Biol (1981) 1.36

Structural basis of DNA bridging by barrier-to-autointegration factor. Biochemistry (2000) 1.35

Cloning of the A gene of bacteriophage Mu and purification of its product, the Mu transposase. J Biol Chem (1985) 1.32

DNase protection analysis of the stable synaptic complexes involved in Mu transposition. Proc Natl Acad Sci U S A (1991) 1.31

Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase. Nucleic Acids Res (1994) 1.29

Catenation and supercoiling in the products of bacteriophage lambda integrative recombination in vitro. J Mol Biol (1980) 1.25